| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |